Delivery Systems, Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Conditions
Brief summary
This trial is conducted in the United States of America (USA). The aim of this trial is to investigate if a 31 gauge x 6 mm needle will provide comparable blood glucose control to the 29 gauge x 12.7 mm needle in obese subjects with diabetes.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Diabetes mellitus * Current treatment with insulin or insulin analogues for the last 6 months * BMI greater than or equal to 30.0 kg/m2 * Currently injecting in the thigh or abdomen * HbA1c below 10%
Exclusion criteria
* Severe, uncontrolled hypertension * Self-mixing insulin * Unwillingness to monitor blood glucose * Pregnancy, breast-feeding, intention to become pregnant, or inadequate contraceptive measures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c | after 12 weeks of treatment |
Secondary
| Measure | Time frame |
|---|---|
| Subject preference and handling | — |
| Frequency of hypoglycaemic episodes | — |
| Quality of Life | — |
Countries
United States